Currently, there are 240.50M common shares owned by the public and among those 227.19M shares have been available to trade.
The company’s stock has a 5-day price change of -18.84% and 375.90% over the past three months. GEVO shares are trading 104.31% year to date (YTD), with the 12-month market performance up to 94.26% higher. It has a 12-month low price of $0.48 and touched a high of $3.39 over the same period. GEVO has an average intraday trading volume of 7.56 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.13%, 38.06%, and 146.95% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Gevo Inc (NASDAQ: GEVO) shares accounts for 23.31% of the company’s 240.50M shares outstanding.
It has a market capitalization of $545.62M and a beta (3y monthly) value of 2.97. The earnings-per-share (ttm) stands at -$0.31. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.87% over the week and 13.01% over the month.
Earnings per share for the fiscal year are expected to decrease by -12.93%, and 11.17% over the next financial year. EPS should shrink at an annualized rate of 25.00% over the next five years, compared to 45.44% over the past 5-year period.
Looking at the support for the GEVO, a number of firms have released research notes about the stock. Northland Capital stated their Market Perform rating for the stock in a research note on August 21, 2023, with the firm’s price target at $2. UBS coverage for the Gevo Inc (GEVO) stock in a research note released on December 14, 2022 offered a Neutral rating with a price target of $2.25. Jefferies was of a view on October 19, 2022 that the stock is Hold, while Citigroup gave the stock Buy rating on February 09, 2022, issuing a price target of $5. Stifel on their part issued Buy rating on August 24, 2021.
